Veeva Expands Basics Suite as Over 100 Biotechs Adopt Platform for Scalable Growth

By Habib Ur Rehman | November 15, 2025, 11:42 PM

Veeva Systems Inc. (NYSE:VEEV) is one of the best digital health stocks to buy now.

On November 4, 2025, Veeva announced that its Veeva Basics solution has been adopted by “more than 100 biotechs” to standardize and scale operations across clinical, regulatory, and quality functions. The press release emphasises that Veeva Basics is built on the company’s Vault Platform, enabling emerging biotech firms to deploy best‑practice workflows quickly and transition to a full Vault solution later with no migration required.

Among the newly announced capabilities are two add‑on applications: LIMS Basics for laboratory oversight and batch release operations, and PromoMats Basics for content lifecycle management including promotional content and claims.

Veeva Expands Basics Suite as Over 100 Biotechs Adopt Platform for Scalable Growth
everything possible/Shutterstock.com

Community testimonials in the release highlight how early adopters appreciate pre‑configured templates, rapid implementation and a scalable path forward. One biotech stated that knowing “we have an agile solution that works now, while providing easy access to the Veeva Vault Platform as we grow” gives them peace of mind.

For investors, this announcement underscores Veeva’s role in the emerging‑biotech segment, a market where rapid scale, regulatory compliance and cost‑efficiency are increasingly critical. The uptake by over 100 firms signals momentum in Veeva’s growth strategy within the life‑sciences tools sector.

Veeva Systems Inc. (NYSE:VEEV) is a cloud‑software company focused on life‑sciences organizations. Its offerings include platforms for clinical, regulatory, quality, commercial and data solutions, serving pharmaceutical companies as well as emerging biotechnology firms.

While we acknowledge the potential of VEEV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None.

Mentioned In This Article

Latest News